WHO in 2011 estimated an increasing burden from non-communicable diseases (NCDs) worldwide due to changing fertility rates, increasing longevity, and changing lifestyles. They estimated 57 million deaths occurring globally in 2011, almost two thirds were deaths from NCDs (WHO, 2011). The morbidity and mortality from NCDs are set to further increase over the next few decades, and for cancer, more than 20 million new cases are anticipated worldwide in 2025, with four fifths of the burden falling on low- and middle-income countries (LMICs) (Bray, 2014). According to World Health Organization (WHO) estimates in 2011, cancer is now the leading cause of death worldwide.

In 2013, WHO have made an action plan and its monitoring framework to reduce 25% premature mortality from cancer and the other major NCDs (cardiovascular diseases, respiratory diseases, and diabetes) by 2025. This action plan has to be the concern of ANCCA group members.

ANCCA (Asian National Cancer Centers Alliance) is the alliance of National Cancer Center (NCC) or a regional cooperative network for cancer in Asia Pacific countries that have been establish since 2005 by 9 countries, include Japan and Singapore. Indonesia joined ANCCA in 2009 during the third ANCCA meeting in China. The sixth ANCCA meeting of 2016 was held in Mongolia attended by 14-member countries and appointed Indonesia as the host of the seventh meeting. It is expected that the seventh ANCCA meeting in Indonesia will also be attended by at least 14-member states of ANCCA. The 14 members of ANCCA are from Bangladesh, China, India, Indonesia, Japan, Korea, Malaysia, Mongolia, Nepal, Pakistan, Singapore, Thailand, Turkey and Vietnam.

The main concern of the ANCCA meeting is to enhance cooperation and institutional equality, especially in cancer services, education, research and the provision of data on cancer burden in Asia. Cancer in Asia may have its own characteristics that require prevention, early detection and special therapy so that there is a need for a special discussion about cancer for the Asian population.

Dharmais Cancer Hospital has been appointed as National Cancer Center in Indonesia. As the National Cancer Center, Dharmais Cancer Hospital is a pilot for other hospitals in Indonesia in terms of cancer control activities from promotion, early detection, diagnosis, therapy, rehabilitation and palliative, including cancer registration according to international standards because Dharmais Cancer Hospital has also been designated as the National Cancer Burden Data Center. So in the activities of this ANCCA’s 7th Meeting, Dharmais Cancer Center will invite other hospitals, especially 14 national reference hospitals, namely:

Expected participants are all the officers involved in cancer control, who work in hospitals such as clinicians, doctors, nurses, pharmacists, medical records, nutritionists, researchers and cancer registrationsas well as from Ministry of Health, primary health centers, private clinics, universities/institutes and organizations that concern of cancer.